CN Stock MarketDetailed Quotes

688046 GemPharmatech

Watchlist
  • 11.49
  • +0.12+1.06%
Market Closed Apr 29 15:00 CST
4.71BMarket Cap42.71P/E (TTM)

GemPharmatech Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2025
(FY)Dec 31, 2024
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
Total operating revenue
8.76%170.86M
10.39%686.84M
12.13%509.72M
15.05%340.38M
11.96%157.09M
20.45%622.19M
17.68%454.56M
18.17%295.86M
20.82%140.3M
31.17%516.55M
Operating revenue
8.76%170.86M
10.39%686.84M
12.13%509.72M
15.05%340.38M
11.96%157.09M
20.45%622.19M
17.68%454.56M
18.17%295.86M
20.82%140.3M
31.17%516.55M
Total operating cost
6.68%135.71M
19.35%580.19M
18.59%414.79M
16.01%267.44M
16.41%127.21M
23.98%486.13M
22.50%349.77M
29.83%230.52M
30.12%109.28M
35.20%392.09M
Operating cost
18.16%63.12M
29.54%261.05M
32.08%185.29M
29.51%120.75M
24.03%53.42M
36.33%201.52M
35.87%140.29M
50.88%93.24M
59.21%43.07M
46.23%147.82M
Operating tax surcharges
161.35%965.38K
47.61%3.9M
97.00%2.34M
61.42%1.29M
-8.88%369.39K
53.47%2.64M
33.17%1.19M
9.39%801.47K
184.10%405.38K
8.21%1.72M
Operating expense
10.92%24.73M
30.32%107.15M
27.65%72.78M
16.36%44.91M
23.39%22.3M
7.71%82.22M
-1.74%57.01M
6.11%38.6M
5.35%18.07M
42.77%76.34M
Administration expense
-0.29%30.91M
12.90%132.54M
12.07%97.66M
16.58%64.72M
16.17%31.01M
19.27%117.39M
18.30%87.14M
17.56%55.51M
19.80%26.69M
21.59%98.43M
Financial expense
20.79%-2.28M
18.62%-11.58M
43.86%-6.27M
35.36%-5.23M
9.77%-2.88M
5.99%-14.23M
5.70%-11.17M
-12.72%-8.08M
-682.77%-3.2M
-564.02%-15.14M
-Interest expense (Financial expense)
10.05%1.08M
55.73%4.3M
83.74%3.35M
101.13%2.16M
149.33%979.08K
457.32%2.76M
752.20%1.82M
202.10%1.07M
44.16%392.69K
-33.47%495.53K
-Interest Income (Financial expense)
42.35%-2.23M
16.02%-14.39M
13.72%-10.9M
13.57%-7.05M
-0.31%-3.87M
-20.29%-17.13M
-19.99%-12.63M
-19.99%-8.16M
-422.08%-3.85M
-330.03%-14.24M
Research and development
-20.63%18.26M
-9.80%87.13M
-16.35%62.99M
-18.78%40.98M
-5.07%23M
16.48%96.6M
22.38%75.31M
30.68%50.46M
36.45%24.23M
50.23%82.93M
Credit Impairment Loss
-1.45%-3.17M
65.12%-3.28M
2.73%-9.51M
-13.23%-8.11M
-4.64%-3.13M
-36.88%-9.39M
-100.71%-9.77M
-35.54%-7.16M
32.20%-2.99M
1.37%-6.86M
Asset Impairment Loss
8.87%-5.89M
0.37%-21.64M
-20.33%-16.68M
-27.65%-12.78M
-12.20%-6.46M
-42.14%-21.72M
-37.43%-13.86M
-65.82%-10.01M
-120.41%-5.76M
-8.55%-15.28M
Adjustment items of total operating cost
----
----
--0.01
----
--0.01
----
----
-100.00%-0.02
----
----
Other net revenue
Fair value change income
-5.19%1.16M
-14.10%2.34M
106.99%2.3M
50.51%2.37M
-47.87%1.22M
6,058.80%2.73M
-87.28%1.11M
-44.51%1.58M
1,379.13%2.34M
-114.30%-45.74K
Invest income
-93.04%289.6K
-30.51%8M
-21.10%7.64M
9.35%6.72M
517.78%4.16M
21.40%11.52M
105.50%9.68M
80.09%6.15M
-57.35%673.48K
-14.64%9.49M
-Including: Investment income associates
-1,890.22%-1.14M
-576.49%-3.15M
-287.14%-860.09K
-121.18%-106.45K
-78.47%63.78K
142.95%662.13K
258.84%459.6K
367.32%502.61K
266.64%296.18K
-2,099.40%-1.54M
Asset deal income
---56.12K
172.80%12.52K
72.43%-4.74K
----
----
82.96%-17.19K
82.96%-17.19K
82.07%-17.19K
----
---100.89K
Other revenue
25.70%3.2M
-38.73%27.28M
-36.08%20.55M
-37.00%16.26M
-64.73%2.55M
-28.53%44.53M
-30.79%32.14M
0.48%25.81M
-11.42%7.22M
26.89%62.3M
Adjusted Items effecting operating profit
----
----
----
200.00%0.01
----
----
----
---0.01
----
--0.01
Operating profit
8.73%30.67M
-27.08%119.37M
-20.04%99.21M
-5.22%77.42M
-13.23%28.21M
-5.90%163.69M
-14.77%124.07M
-12.47%81.69M
-7.05%32.51M
21.42%173.95M
Add:Non operating Income
--0.01
85.21%14.01K
-99.99%4.28
-39.59%1.48
----
264,432.87%7.57K
4,975,445.61%85.08K
920.83%2.45
684.62%1.02
-99.99%2.86
Less:Non operating expense
----
-93.07%166.82K
-89.63%11.82K
-25.09%7.53K
--6.3K
785.75%2.41M
-58.06%114K
-51.63%10.06K
----
411,133.10%271.83K
Add:Adjusted items effecting total profit
----
----
----
----
----
----
--0.01
----
----
----
Total profit
8.75%30.67M
-26.09%119.21M
-20.03%99.2M
-5.22%77.41M
-13.25%28.2M
-7.14%161.29M
-14.63%124.04M
-12.47%81.68M
-7.05%32.51M
21.19%173.68M
Less:Income tax cost
154.39%693.39K
295.81%9.4M
-84.44%984.54K
-73.88%1.07M
-187.20%-1.27M
-73.67%2.37M
-63.17%6.33M
-64.81%4.11M
-68.59%1.46M
-50.97%9.02M
Add:Adjusted items effecting net profit
----
----
----
---0.01
----
----
----
----
----
----
Net profit
1.70%29.98M
-30.89%109.82M
-16.57%98.21M
-1.59%76.34M
-5.06%29.48M
-3.49%158.91M
-8.13%117.71M
-4.98%77.57M
2.39%31.05M
31.81%164.67M
Net profit from continuing operation
1.70%29.98M
-30.89%109.82M
-16.57%98.21M
-1.59%76.34M
-5.06%29.48M
-3.49%158.91M
-8.13%117.71M
-4.98%77.57M
2.39%31.05M
31.81%164.67M
Net profit of parent company owners
1.70%29.98M
-30.89%109.82M
-16.57%98.21M
-1.59%76.34M
-5.06%29.48M
-3.49%158.91M
-8.13%117.71M
-4.98%77.57M
2.39%31.05M
31.81%164.67M
Earning per share
Basic earning per share
0.00%0.07
-30.77%0.27
-17.24%0.24
0.00%0.19
-12.50%0.07
-7.14%0.39
-12.12%0.29
-13.64%0.19
0.00%0.08
20.00%0.42
Diluted earning per share
0.00%0.07
-30.77%0.27
-17.24%0.24
0.00%0.19
-12.50%0.07
-7.14%0.39
-12.12%0.29
-13.64%0.19
0.00%0.08
20.00%0.42
Other composite income
-232.78%-98.32K
4,176.04%7.55M
-149.89%-198.99K
-71.64%138.21K
142.05%74.05K
-72.44%176.65K
-42.23%398.82K
306.74%487.28K
-343.89%-176.07K
65.21%641.06K
Other composite income of parent company owners
-232.78%-98.32K
4,176.04%7.55M
-149.89%-198.99K
-71.64%138.21K
142.05%74.05K
-72.44%176.65K
-42.23%398.82K
306.74%487.28K
-343.89%-176.07K
65.21%641.06K
Total composite income
1.11%29.88M
-26.22%117.37M
-17.02%98.02M
-2.02%76.48M
-4.28%29.55M
-3.76%159.09M
-8.31%118.11M
-4.52%78.06M
1.95%30.87M
31.91%165.31M
Total composite income of parent company owners
1.11%29.88M
-26.22%117.37M
-17.02%98.02M
-2.02%76.48M
-4.28%29.55M
-3.76%159.09M
-8.31%118.11M
-4.52%78.06M
1.95%30.87M
31.91%165.31M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
--
--
--
--
Grant Thornton Certified Public Accountants (Special General Partnership)
--
--
--
Grant Thornton Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2025(FY)Dec 31, 2024(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022
Total operating revenue 8.76%170.86M10.39%686.84M12.13%509.72M15.05%340.38M11.96%157.09M20.45%622.19M17.68%454.56M18.17%295.86M20.82%140.3M31.17%516.55M
Operating revenue 8.76%170.86M10.39%686.84M12.13%509.72M15.05%340.38M11.96%157.09M20.45%622.19M17.68%454.56M18.17%295.86M20.82%140.3M31.17%516.55M
Total operating cost 6.68%135.71M19.35%580.19M18.59%414.79M16.01%267.44M16.41%127.21M23.98%486.13M22.50%349.77M29.83%230.52M30.12%109.28M35.20%392.09M
Operating cost 18.16%63.12M29.54%261.05M32.08%185.29M29.51%120.75M24.03%53.42M36.33%201.52M35.87%140.29M50.88%93.24M59.21%43.07M46.23%147.82M
Operating tax surcharges 161.35%965.38K47.61%3.9M97.00%2.34M61.42%1.29M-8.88%369.39K53.47%2.64M33.17%1.19M9.39%801.47K184.10%405.38K8.21%1.72M
Operating expense 10.92%24.73M30.32%107.15M27.65%72.78M16.36%44.91M23.39%22.3M7.71%82.22M-1.74%57.01M6.11%38.6M5.35%18.07M42.77%76.34M
Administration expense -0.29%30.91M12.90%132.54M12.07%97.66M16.58%64.72M16.17%31.01M19.27%117.39M18.30%87.14M17.56%55.51M19.80%26.69M21.59%98.43M
Financial expense 20.79%-2.28M18.62%-11.58M43.86%-6.27M35.36%-5.23M9.77%-2.88M5.99%-14.23M5.70%-11.17M-12.72%-8.08M-682.77%-3.2M-564.02%-15.14M
-Interest expense (Financial expense) 10.05%1.08M55.73%4.3M83.74%3.35M101.13%2.16M149.33%979.08K457.32%2.76M752.20%1.82M202.10%1.07M44.16%392.69K-33.47%495.53K
-Interest Income (Financial expense) 42.35%-2.23M16.02%-14.39M13.72%-10.9M13.57%-7.05M-0.31%-3.87M-20.29%-17.13M-19.99%-12.63M-19.99%-8.16M-422.08%-3.85M-330.03%-14.24M
Research and development -20.63%18.26M-9.80%87.13M-16.35%62.99M-18.78%40.98M-5.07%23M16.48%96.6M22.38%75.31M30.68%50.46M36.45%24.23M50.23%82.93M
Credit Impairment Loss -1.45%-3.17M65.12%-3.28M2.73%-9.51M-13.23%-8.11M-4.64%-3.13M-36.88%-9.39M-100.71%-9.77M-35.54%-7.16M32.20%-2.99M1.37%-6.86M
Asset Impairment Loss 8.87%-5.89M0.37%-21.64M-20.33%-16.68M-27.65%-12.78M-12.20%-6.46M-42.14%-21.72M-37.43%-13.86M-65.82%-10.01M-120.41%-5.76M-8.55%-15.28M
Adjustment items of total operating cost ----------0.01------0.01---------100.00%-0.02--------
Other net revenue
Fair value change income -5.19%1.16M-14.10%2.34M106.99%2.3M50.51%2.37M-47.87%1.22M6,058.80%2.73M-87.28%1.11M-44.51%1.58M1,379.13%2.34M-114.30%-45.74K
Invest income -93.04%289.6K-30.51%8M-21.10%7.64M9.35%6.72M517.78%4.16M21.40%11.52M105.50%9.68M80.09%6.15M-57.35%673.48K-14.64%9.49M
-Including: Investment income associates -1,890.22%-1.14M-576.49%-3.15M-287.14%-860.09K-121.18%-106.45K-78.47%63.78K142.95%662.13K258.84%459.6K367.32%502.61K266.64%296.18K-2,099.40%-1.54M
Asset deal income ---56.12K172.80%12.52K72.43%-4.74K--------82.96%-17.19K82.96%-17.19K82.07%-17.19K-------100.89K
Other revenue 25.70%3.2M-38.73%27.28M-36.08%20.55M-37.00%16.26M-64.73%2.55M-28.53%44.53M-30.79%32.14M0.48%25.81M-11.42%7.22M26.89%62.3M
Adjusted Items effecting operating profit ------------200.00%0.01---------------0.01------0.01
Operating profit 8.73%30.67M-27.08%119.37M-20.04%99.21M-5.22%77.42M-13.23%28.21M-5.90%163.69M-14.77%124.07M-12.47%81.69M-7.05%32.51M21.42%173.95M
Add:Non operating Income --0.0185.21%14.01K-99.99%4.28-39.59%1.48----264,432.87%7.57K4,975,445.61%85.08K920.83%2.45684.62%1.02-99.99%2.86
Less:Non operating expense -----93.07%166.82K-89.63%11.82K-25.09%7.53K--6.3K785.75%2.41M-58.06%114K-51.63%10.06K----411,133.10%271.83K
Add:Adjusted items effecting total profit --------------------------0.01------------
Total profit 8.75%30.67M-26.09%119.21M-20.03%99.2M-5.22%77.41M-13.25%28.2M-7.14%161.29M-14.63%124.04M-12.47%81.68M-7.05%32.51M21.19%173.68M
Less:Income tax cost 154.39%693.39K295.81%9.4M-84.44%984.54K-73.88%1.07M-187.20%-1.27M-73.67%2.37M-63.17%6.33M-64.81%4.11M-68.59%1.46M-50.97%9.02M
Add:Adjusted items effecting net profit ---------------0.01------------------------
Net profit 1.70%29.98M-30.89%109.82M-16.57%98.21M-1.59%76.34M-5.06%29.48M-3.49%158.91M-8.13%117.71M-4.98%77.57M2.39%31.05M31.81%164.67M
Net profit from continuing operation 1.70%29.98M-30.89%109.82M-16.57%98.21M-1.59%76.34M-5.06%29.48M-3.49%158.91M-8.13%117.71M-4.98%77.57M2.39%31.05M31.81%164.67M
Net profit of parent company owners 1.70%29.98M-30.89%109.82M-16.57%98.21M-1.59%76.34M-5.06%29.48M-3.49%158.91M-8.13%117.71M-4.98%77.57M2.39%31.05M31.81%164.67M
Earning per share
Basic earning per share 0.00%0.07-30.77%0.27-17.24%0.240.00%0.19-12.50%0.07-7.14%0.39-12.12%0.29-13.64%0.190.00%0.0820.00%0.42
Diluted earning per share 0.00%0.07-30.77%0.27-17.24%0.240.00%0.19-12.50%0.07-7.14%0.39-12.12%0.29-13.64%0.190.00%0.0820.00%0.42
Other composite income -232.78%-98.32K4,176.04%7.55M-149.89%-198.99K-71.64%138.21K142.05%74.05K-72.44%176.65K-42.23%398.82K306.74%487.28K-343.89%-176.07K65.21%641.06K
Other composite income of parent company owners -232.78%-98.32K4,176.04%7.55M-149.89%-198.99K-71.64%138.21K142.05%74.05K-72.44%176.65K-42.23%398.82K306.74%487.28K-343.89%-176.07K65.21%641.06K
Total composite income 1.11%29.88M-26.22%117.37M-17.02%98.02M-2.02%76.48M-4.28%29.55M-3.76%159.09M-8.31%118.11M-4.52%78.06M1.95%30.87M31.91%165.31M
Total composite income of parent company owners 1.11%29.88M-26.22%117.37M-17.02%98.02M-2.02%76.48M-4.28%29.55M-3.76%159.09M-8.31%118.11M-4.52%78.06M1.95%30.87M31.91%165.31M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ----------Unqualified opinion------Unqualified opinion
Auditor ----------Grant Thornton Certified Public Accountants (Special General Partnership)------Grant Thornton Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
Sample Name
Sample Code
 +20.01%
Sample Name
Sample Code
 +20.01%
Sample Name
Sample Code
 +20.01%
4
Jing-Jin Electric Technologies
688280
+20.00%
5
Hangzhou Anysoft Information Technology
300571
+20.00%
Unlock Now

Discussing

2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current Show More
Warren Buffett Stands Tall as U.S. Stocks Tumble: How the 'Oracle' Is Tackling Tariff Impacts

Investment Course

How to Buy Stocks for Beginners
Learn stock market basics and confidently start investing with our beginner-friendly guide to buying stocks. Start your investment journey today!
What Is Options Trading and How to Trade Options
Options trading is carried out by all kinds of investors within individual investment portfolios. Learn how you can put options to work within your own portfolio.
What To Know About Margin Accounts
Discover the essentials of margin accounts, including their benefits, risks, and how to use them effectively in your trading strategy.
Cash Accounts - Covering the Basics
Discover the essentials of cash accounts. Learn what cash accounts are, how they function, their potential benefits, and the differences between cash and margin accounts.
Understanding Fractional Shares: A Beginner's Guide
Discover the basics of fractional shares, how they work, and the process for buying and selling them.

- No more -